December 03, 2016 5:07 PM ET


Company Overview of PTC Therapeutics, Inc.

Key Executives for PTC Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Stuart W. Peltz Ph.D.136 RelationshipsCo-Founder, Chief Executive Officer and Executive Director56
Allan Steven Jacobson Ph.D.13 RelationshipsCo-Founder, Chairman of Scientific Advisory Board and Director70
Shane William Charles Kovacs No RelationshipsChief Financial Officer, Head of Corporate Development and Executive Vice President42
John Babiak Ph.D.No RelationshipsSenior Vice President of Drug Discovery Technologies59
Mark Elliott Boulding No RelationshipsChief Legal Officer and Executive Vice President55
View More Key Executives

PTC Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael Schmertzler 13 RelationshipsPTC Therapeutics, Inc.64
Stuart W. Peltz Ph.D. 136 RelationshipsPTC Therapeutics, Inc.56
Allan Steven Jacobson Ph.D. 13 RelationshipsPTC Therapeutics, Inc.70
David P. Southwell 41 RelationshipsInotek Pharmaceuticals Corporation55
Ronald C. Renaud Jr., MBA 47 RelationshipsRaNA Therapeutics, Inc.47
View All Board Members

PTC Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr., MBARonald C. Renaud47 Relationships2 Executives
Compensation Committee David P. Southwell41 Relationships3 Executives
Nominating Committee Michael Schmertzler13 Relationships2 Executives
Corporate Governance Committee Michael Schmertzler13 Relationships2 Executives
Advisory Board Ph.D.Allan Steven Jacobson13 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$600.0K
Total Value of Options
Compensation as of Fiscal Year
PTC Therapeutics, Inc. CEO Compensation
Industry Average


Tonix Pharmaceuticals Holding Corp. Announces Resignation of Bruce Daugherty as Chief Scientific Officer Controller and Secretary, Effective December 31, 2016
December 02, 2016 9:31 PM ET
Alkermes plc Announces Resignation of Gordon G. Pugh as the Senior Vice President, Chief Operating Officer and Chief Risk Officer, Effective January 3, 2017
December 02, 2016 9:30 PM ET
Oasmia Pharmaceutical AB Announces Executive Changes
December 02, 2016 3:05 PM ET
CytRx Corporation Appoints Earl Warren Brien to its Board of Directors
December 02, 2016 2:00 PM ET
Vertex Pharmaceuticals Incorporated Announces Executive Appointments
December 02, 2016 1:42 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PTC Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at